Home Categories Send inquiry

Sofosbuvir CAS 1190307-88-0 Purity ≥99.0% (HPLC)

Commercial Supply Sofosbuvir and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8

Name Sofosbuvir
CAS Number 1190307-88-0
CAT Number RF-API06
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C22H29FN3O9P
Molecular Weight 529.45
Melting Point 120.0~125.0℃
Density 1.41
Solubility Soluble in DMF, DMSO, Ethanol
Shipping Condition Under Ambient Temperature
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Crystalline Powder
Identification HPLC; RT
Purity / Analysis Method ≥99.0% (HPLC)
E.E ≥99.0%
Loss on Drying ≤1.0% 
Residue on Ignition ≤0.20% 
Single Impurity ≤0.50% 
Total Impurities  ≤1.0% 
Heavy Metals ≤20ppm
Residual Solvents Meet the requirements of specifications
Methanol ≤1500ppm
TBME ≤2500ppm
Dichloromethane ≤720ppm
Tetrahydrofuran ≤720ppm
Toluene ≤60ppm
Test Standard Enterprise Standard
Usage Sofosbuvir (CAS: 1190307-88-0) in the treatment of Hepatitis C Virus (HCV)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Sofosbuvir (CAS: 1190307-88-0) (formally labeled as PSI-797, GS-7977) is a phosphoramidate prodrug and nucleotide polymerase inhibitor for the treatment of chronic hepatitis C virus (HCV) infection. It is recommended to be used in combination with other drugs (such as velpatasvir) for the first-line treatment for HCV genotypes 1, 2, 3, 4, 5, and 6. It takes effect through acting as a nucleotide analog inhibitor, being capable of specially inhibiting the HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase.